Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Choosing the right rewards requires understanding several factors. This guide highlights what you should consider for optimal benefits.
17,200 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Investors and households are bracing for the Federal Reserve's policy decision, with potential moves on borrowing cos...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
A $900,000 business sale in one year can trigger Medicare IRMAA surcharges. Experts say structuring the deal as an in...
U.S. and allied markets surged after reports of a breakthrough with Iran, delivering a risk-on signal across equities...
A new Pew study shows half u.s. adults under 50 seek health guidance from social media influencers rather than doctor...
Illinois becomes the first state to tax every digital asset transfer at 0.2%, a move that could reshape crypto flows....
Savers in 2026 face a choice between money market accounts high and high-yield savings. This article breaks down how ...
As inflation keeps costs high, more households are assisting adult children. This report outlines practical, doable t...
Austria's stock rally accelerates as banks lift the EWO ETF, but the upside may be thinning as net interest margins c...
The FCC's proposed rules to curb illegal robocalls could unintentionally broaden the data telecoms hold on users, boo...
Pfizer’s stock has faced waves of headwinds, but a patient, long-term view can reveal an opportunity. This guide expl...